Royal Bank of Canada’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,758
| Closed | -$2.08M | – | 7653 |
|
|
2022
Q3 | $2.08M | Sell |
13,758
-11,539
| -46% | -$1.74M | ﹤0.01% | 2455 |
|
|
2022
Q2 | $3.69M | Sell |
25,297
-14,934
| -37% | -$2.18M | ﹤0.01% | 2057 |
|
|
2022
Q1 | $4.77M | Sell |
40,231
-1,068
| -3% | -$127K | ﹤0.01% | 1995 |
|
|
2021
Q4 | $5.69M | Buy |
41,299
+24,666
| +148% | +$3.4M | ﹤0.01% | 1950 |
|
|
2021
Q3 | $2.31M | Sell |
16,633
-10,841
| -39% | -$1.51M | ﹤0.01% | 2577 |
|
|
2021
Q2 | $2.67M | Sell |
27,474
-5,866
| -18% | -$569K | ﹤0.01% | 2479 |
|
|
2021
Q1 | $2.28M | Sell |
33,340
-6,153
| -16% | -$421K | ﹤0.01% | 2532 |
|
|
2020
Q4 | $3.39M | Buy |
39,493
+21,671
| +122% | +$1.86M | ﹤0.01% | 2137 |
|
|
2020
Q3 | $1.16M | Sell |
17,822
-2,549
| -13% | -$166K | ﹤0.01% | 2744 |
|
|
2020
Q2 | $1.49M | Buy |
20,371
+18,786
| +1,185% | +$1.37M | ﹤0.01% | 2491 |
|
|
2020
Q1 | $54K | Sell |
1,585
-8,364
| -84% | -$285K | ﹤0.01% | 4626 |
|
|
2019
Q4 | $542K | Buy |
9,949
+8,483
| +579% | +$462K | ﹤0.01% | 3376 |
|
|
2019
Q3 | $62K | Sell |
1,466
-3,377
| -70% | -$143K | ﹤0.01% | 4451 |
|
|
2019
Q2 | $212K | Buy |
4,843
+4,488
| +1,264% | +$196K | ﹤0.01% | 3891 |
|
|
2019
Q1 | $18K | Buy |
355
+42
| +13% | +$2.13K | ﹤0.01% | 4929 |
|
|
2018
Q4 | $12K | Sell |
313
-595
| -66% | -$22.8K | ﹤0.01% | 5061 |
|
|
2018
Q3 | $33K | Buy |
908
+631
| +228% | +$22.9K | ﹤0.01% | 4837 |
|
|
2018
Q2 | $10K | Buy |
277
+129
| +87% | +$4.66K | ﹤0.01% | 5259 |
|
|
2018
Q1 | $4K | Buy |
148
+72
| +95% | +$1.95K | ﹤0.01% | 5413 |
|
|
2017
Q4 | $2K | Sell |
76
-849
| -92% | -$22.3K | ﹤0.01% | 5589 |
|
|
2017
Q3 | $34K | Buy |
+925
| New | +$34K | ﹤0.01% | 4916 |
|